FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4290730488> ?p ?o ?g. }

• W4290730488 abstract "Atopic dermatitis (AD) is a common autoimmune and chronic inflammatory cutaneous disease with a relapsing-remitting course. Necroptosis is a regulated necrotic cell death mediated by receptor-interacting protein 1 (RIP1), receptor-interacting protein 3 (RIP3), and mixed lineage kinase domain-like pseudokinase (MLKL), which is activated by tumor necrosis factor-α (TNF-α). However, the mechanism and the role of necroptosis have not been delineated in AD progression. (-)-Epigallocatechin-3-gallate (EGCG), the main biological activity of tea catechin, is well known for its beneficial effects in the treatment of skin diseases. Here, PEG-PLGA-EGCG nanoparticles (EGCG-NPs) were formulated to investigate the bioavailability of EGCG to rescue cellular injury following the inhibition of necroptosis after AD. 2,4-dinitrochlorobenzene (DNCB) was used to establish AD mouse models. As expected, topically applied EGCG-NPs elicited a significant amelioration of AD symptoms in skin lesions, including reductions in the ear and skin thickness, dermatitis score, and scratching behavior, which was accompanied by redox homeostasis restored early in the experiment. In addition, EGCG-NPs significantly decreased the expression of inflammatory cytokines like TNF-α, interferon-γ (IFN-γ), interleukin-4 (IL-4), interleukin-6 (IL-6), and interleukin-17A (IL-17A) in a time-dependent manner than those of in AD group. As a result, the overexpression of RIP1, RIP3, and MLKL in the entire epidermis layers was dramatically blocked by EGCG-NPs, as well as the expression ofphosphorylated p38 (p-p38), extracellular signal-regulated kinase 1 (ERK1), and extracellular signal-regulated kinase 2 (ERK2). These findings promote that EGCG-NPs formulation represents a promising drug-delivery strategy for the treatment of AD by maintaining the balance of Th1/Th2 inflammation response and targeting necroptosis." @default.
• W4290730488 created "2022-08-09" @default.
• W4290730488 creator A5013281137 @default.
• W4290730488 creator A5032764121 @default.
• W4290730488 creator A5040558103 @default.
• W4290730488 creator A5058372572 @default.
• W4290730488 creator A5065172118 @default.
• W4290730488 creator A5079838313 @default.
• W4290730488 creator A5091665121 @default.
• W4290730488 date "2022-08-09" @default.
• W4290730488 modified "2023-09-25" @default.
• W4290730488 title "Ameliorative effects of epigallocatechin-3-gallate nanoparticles on 2,4-dinitrochlorobenzene induced atopic dermatitis: A potential mechanism of inflammation-related necroptosis" @default.
• W4290730488 cites W1181485659 @default.
• W4290730488 cites W1586591061 @default.
• W4290730488 cites W1971322330 @default.
• W4290730488 cites W1974018362 @default.
• W4290730488 cites W1979032223 @default.
• W4290730488 cites W1994262603 @default.
• W4290730488 cites W1996725694 @default.
• W4290730488 cites W1998983498 @default.
• W4290730488 cites W2008961838 @default.
• W4290730488 cites W2029673387 @default.
• W4290730488 cites W2037645507 @default.
• W4290730488 cites W2063760582 @default.
• W4290730488 cites W2065844939 @default.
• W4290730488 cites W2069016591 @default.
• W4290730488 cites W2072540607 @default.
• W4290730488 cites W2084914240 @default.
• W4290730488 cites W2093680901 @default.
• W4290730488 cites W2099314511 @default.
• W4290730488 cites W2129627069 @default.
• W4290730488 cites W2145110135 @default.
• W4290730488 cites W2147280137 @default.
• W4290730488 cites W2323272925 @default.
• W4290730488 cites W2467873726 @default.
• W4290730488 cites W2469321406 @default.
• W4290730488 cites W2518396575 @default.
• W4290730488 cites W2548188182 @default.
• W4290730488 cites W2586088194 @default.
• W4290730488 cites W2586378708 @default.
• W4290730488 cites W2602127159 @default.
• W4290730488 cites W2602842300 @default.
• W4290730488 cites W2783511984 @default.
• W4290730488 cites W2797624079 @default.
• W4290730488 cites W2797828501 @default.
• W4290730488 cites W2810820884 @default.
• W4290730488 cites W2892288216 @default.
• W4290730488 cites W2894891859 @default.
• W4290730488 cites W290172342 @default.
• W4290730488 cites W2906681724 @default.
• W4290730488 cites W2907756900 @default.
• W4290730488 cites W2917503096 @default.
• W4290730488 cites W2920901214 @default.
• W4290730488 cites W2952088410 @default.
• W4290730488 cites W2973831916 @default.
• W4290730488 cites W2974993717 @default.
• W4290730488 cites W3000524409 @default.
• W4290730488 cites W3006693838 @default.
• W4290730488 cites W3007636517 @default.
• W4290730488 cites W3015611293 @default.
• W4290730488 cites W3036548564 @default.
• W4290730488 cites W3089741050 @default.
• W4290730488 cites W3091172085 @default.
• W4290730488 cites W3126549917 @default.
• W4290730488 cites W3133166028 @default.
• W4290730488 cites W3164651322 @default.
• W4290730488 cites W3164790136 @default.
• W4290730488 cites W3173595877 @default.
• W4290730488 cites W3179548290 @default.
• W4290730488 cites W3186229379 @default.
• W4290730488 cites W3210906481 @default.
• W4290730488 cites W3216985247 @default.
• W4290730488 doi "https://doi.org/10.3389/fnut.2022.953646" @default.
• W4290730488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36017227" @default.
• W4290730488 hasPublicationYear "2022" @default.
• W4290730488 type Work @default.
• W4290730488 citedByCount "7" @default.
• W4290730488 countsByYear W42907304882023 @default.
• W4290730488 crossrefType "journal-article" @default.
• W4290730488 hasAuthorship W4290730488A5013281137 @default.
• W4290730488 hasAuthorship W4290730488A5032764121 @default.
• W4290730488 hasAuthorship W4290730488A5040558103 @default.
• W4290730488 hasAuthorship W4290730488A5058372572 @default.
• W4290730488 hasAuthorship W4290730488A5065172118 @default.
• W4290730488 hasAuthorship W4290730488A5079838313 @default.
• W4290730488 hasAuthorship W4290730488A5091665121 @default.
• W4290730488 hasBestOaLocation W42907304881 @default.
• W4290730488 hasConcept C17991360 @default.
• W4290730488 hasConcept C184235292 @default.
• W4290730488 hasConcept C185592680 @default.
• W4290730488 hasConcept C190283241 @default.
• W4290730488 hasConcept C203014093 @default.
• W4290730488 hasConcept C2776914184 @default.
• W4290730488 hasConcept C2777192995 @default.
• W4290730488 hasConcept C2778004101 @default.
• W4290730488 hasConcept C2778690821 @default.
• W4290730488 hasConcept C31573885 @default.
• W4290730488 hasConcept C502942594 @default.
• W4290730488 hasConcept C51551487 @default.
• W4290730488 hasConcept C55493867 @default.

• next